POSC258 Acceptance of Progression-Free Survival 2 (PFS2) By EU5 and Canadian Health Authorities for Cancer Drug Reimbursement
Abstract
Authors
E Rizzello C Leopaldi B Massó A Vidalis P Kachouh A Bechara J Milnes
E Rizzello C Leopaldi B Massó A Vidalis P Kachouh A Bechara J Milnes
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now